Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | EVP, Corp Strategy & Develop | August 10, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,041 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Gift · Disposed 257 · Balance 31,041 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2019 Filed Mar 12, 2019 11:58 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $137.85 | $27,570.00 |
DisclosureSEC source: 0001127602-19-010921 · form4.xml · nonDerivative · entry 2 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,449 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:58 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $137.84 | $27,567.00 |
DisclosureSEC source: 0001127602-19-010921 · form4.xml · nonDerivative · entry 1 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,649 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $138.37 | $13,837.00 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 12 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,413 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 3 | $138.30 | $414.90 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 11 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,513 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $138.28 | $27,656.00 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 10 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,516 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $138.26 | $13,826.00 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 9 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,716 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $138.24 | $13,824.00 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 8 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,816 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $138.23 | $41,469.00 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 7 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,916 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $138.22 | $41,466.00 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 6 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,216 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 30 | $138.21 | $4,146.15 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 5 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,516 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $138.20 | $41,460.00 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 4 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,546 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 3 | $138.20 | $414.59 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 3 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,846 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 30 | $138.19 | $4,145.70 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 2 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,849 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 12:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $138.18 | $27,636.00 |
DisclosureSEC source: 0001127602-19-010923 · form4.xml · nonDerivative · entry 1 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,879 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,204 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · derivative · entry 34 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,614 Underlying: Common Stock · 3,204 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,492 | $0.00 Strike: $88.05 | $0.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · derivative · entry 33 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,985 Underlying: Common Stock · 3,492 shares Expires 2022-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,350 | $0.00 Strike: $73.70 | $0.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · derivative · entry 32 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350 Underlying: Common Stock · 3,350 shares Expires 2021-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 1,542 | $0.00 Strike: $76.67 | $0.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · derivative · entry 31 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,542 shares Expires 2020-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $137.82 | $41,346.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 30 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,849 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 114 | $137.81 | $15,710.34 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 29 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,149 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $137.80 | $41,340.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 28 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,263 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $137.77 | $13,777.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 27 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,563 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $137.76 | $13,776.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 26 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,663 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $137.75 | $13,775.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 25 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,763 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $137.74 | $27,548.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 24 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,863 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $137.74 | $13,773.50 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 23 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,063 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 500 | $137.73 | $68,865.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 22 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,163 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $137.72 | $27,544.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 21 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,663 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $137.71 | $13,771.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 20 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,863 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 6 | $137.67 | $825.99 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 19 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,963 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $137.64 | $41,292.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 18 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,969 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 330 | $137.63 | $45,417.90 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 17 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,269 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 164 | $137.61 | $22,567.22 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 16 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,599 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $137.58 | $13,758.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 15 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,763 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $137.56 | $41,268.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 14 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,863 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 308 | $137.53 | $42,359.24 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 13 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,163 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $137.52 | $27,503.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 12 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,471 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $137.50 | $13,749.50 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 11 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,671 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $137.48 | $54,992.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 10 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,771 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $137.46 | $54,984.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 9 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,171 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 302 | $137.45 | $41,509.90 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 8 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,571 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 198 | $137.44 | $27,213.12 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 7 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,873 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $137.43 | $13,743.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 6 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,071 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $137.42 | $27,483.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 5 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,171 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,204 | $109.34 | $350,325.36 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 4 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,492 | $88.05 | $307,470.60 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 3 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,350 | $73.70 | $246,895.00 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 2 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 11:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 1,542 | $76.67 | $118,225.14 |
DisclosureSEC source: 0001127602-19-010919 · form4.xml · nonDerivative · entry 1 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 14:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 156 | $140.71 | $21,950.76 |
DisclosureSEC source: 0001127602-19-008798 · form4.xml · nonDerivative · entry 2 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,783 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 14:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 304 | $145.31 | $44,174.24 |
DisclosureSEC source: 0001127602-19-008798 · form4.xml · nonDerivative · entry 1 LaPlume Joseph W · CIK 0001767215 · EVP, Corp Strategy & Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,939 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.